How to buy ICU Medical (ICUI) stock

ICU Medical, Inc is a medical instruments & supplies business based in the US. ICU Medical shares (ICUI) are listed on the NASDAQ and all prices are listed in US Dollars. ICU Medical employs 7,900 staff and has a trailing 12-month revenue of around 0.00.

ICU Medical stock price (NASDAQ: ICUI)

Use our graph to track the performance of ICUI stocks over time.

ICU Medical shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$208.06
52-week range	$176.11 - $227.07
50-day moving average	$204.19
200-day moving average	$207.79
Wall St. target price	$240.33
PE ratio	45.3523
Dividend yield	N/A (0%)
Earnings per share (TTM)	$4.33

Buy ICU Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy ICU Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of ICU Medical, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ICU Medical price performance over time

Historical closes compared with the close of $208.06 from 2021-05-28

1 week (2021-07-17)	N/A
1 month (2021-06-28)	1.30%
3 months (2021-04-28)	-2.08%
6 months (2021-01-24)	N/A

1 year (2020-07-24)	N/A
2 years (2019-07-24)	N/A
3 years (2018-07-24)	N/A
5 years (2016-07-24)	N/A

Is ICU Medical under- or over-valued?

Valuing ICU Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ICU Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

ICU Medical's P/E ratio

ICU Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 45x. In other words, ICU Medical shares trade at around 45x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

ICU Medical's PEG ratio

ICU Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.7034. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ICU Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

ICU Medical's EBITDA

ICU Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $212.6 million.

The EBITDA is a measure of a ICU Medical's overall financial performance and is widely used to measure a its profitability.

ICU Medical financials

Revenue TTM	$1.3 billion
Operating margin TTM	9.98%
Gross profit TTM	$461.5 million
Return on assets TTM	4.39%
Return on equity TTM	6.47%
Profit margin	7.44%
Book value	$71.76
Market capitalisation	$4.2 billion

TTM: trailing 12 months

Shorting ICU Medical shares

There are currently 472,147 ICU Medical shares held short by investors – that's known as ICU Medical's "short interest". This figure is 13.7% up from 415,285 last month.

There are a few different ways that this level of interest in shorting ICU Medical shares can be evaluated.

ICU Medical's "short interest ratio" (SIR)

ICU Medical's "short interest ratio" (SIR) is the quantity of ICU Medical shares currently shorted divided by the average quantity of ICU Medical shares traded daily (recently around 85844.909090909). ICU Medical's SIR currently stands at 5.5. In other words for every 100,000 ICU Medical shares traded daily on the market, roughly 5500 shares are currently held short.

However ICU Medical's short interest can also be evaluated against the total number of ICU Medical shares, or, against the total number of tradable ICU Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ICU Medical's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 ICU Medical shares in existence, roughly 20 shares are currently held short) or 0.0237% of the tradable shares (for every 100,000 tradable ICU Medical shares, roughly 24 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against ICU Medical.

Find out more about how you can short ICU Medical stock.

ICU Medical share dividends

We're not expecting ICU Medical to pay a dividend over the next 12 months.

Have ICU Medical's shares ever split?

ICU Medical's shares were split on a 3:2 basis on 17 March 2002. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your ICU Medical shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for ICU Medical shares which in turn could have impacted ICU Medical's share price.

ICU Medical share price volatility

Over the last 12 months, ICU Medical's shares have ranged in value from as little as $176.11 up to $227.07. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ICU Medical's is 0.5958. This would suggest that ICU Medical's shares are less volatile than average (for this exchange).

ICU Medical overview

ICU Medical, Inc. , together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. Further, it provides critical care products comprising Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities.

Frequently asked questions

What percentage of ICU Medical is owned by insiders or institutions?
Currently 6.432% of ICU Medical shares are held by insiders and 96.736% by institutions. How many people work for ICU Medical?
Latest data suggests 7,900 work at ICU Medical. When does the fiscal year end for ICU Medical?
ICU Medical's fiscal year ends in December. Where is ICU Medical based?
ICU Medical's address is: 951 Calle Amanecer, San Clemente, CA, United States, 92673 What is ICU Medical's ISIN number?
ICU Medical's international securities identification number is: US44930G1076 What is ICU Medical's CUSIP number?
ICU Medical's Committee on Uniform Securities Identification Procedures number is: 44930G107